Inhaler Group UK Explore the Impact of Inhaled Therapies Next March in London
Summary
Other sessions which are not to be missed include insightful presentations from: MHRA, GSK, Boehringer Ingelheim, Glenmark Pharmaceuticals, Janssen, Novartis, Teva, AstraZeneca, MedImmune, Mylan, Imperial College of London, Actavis and many more...We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network.More information can be found at http://www.smi-online.co.uk London, United Kingdom, December 15, 2016 --( PR.com )-- Monica Fletcher OBE, Chief Executive of Education for Health and Chair of the UK Inhaler Group joins this year’s speaker panel for Asthma & COPD 2017.Therefore it highlights the need to address so many ongoing issues regarding these two respiratory diseases.Other sessions which are not to be missed include insightful presentations from: MHRA, GSK, Boehringer Ingelheim, Glenmark Pharmaceuticals, Janssen, Novartis, Teva, AstraZeneca, MedImmune, Mylan, Imperial College of London, Actavis and many more...Hot topics for the 2017 agenda include: regulatory updates, therapeutic developments, COPD updates, novel approaches to treatment and electronic health monitoring.Two CPD certified pre-conference workshops will be hosted alongside the conference by Cambridge Consultants and Janssen.There is currently an early bird offer available; book by 16th of December to save £200 off the conference price.We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network.